Rezolute Inc (RZLT)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 0 0 0 58,000
Cost of Revenue 0 0 0 7,000
Gross Profit 0 0 0 51,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 4,740,000 4,453,000 4,187,000 4,013,000
Operating Expenses 20,023,000 17,080,000 16,941,000 23,102,000
Operating Income 0 -17,080,000 -16,941,000 -23,102,000
Interest Expense 0 0 0 0
Income Before Tax -18,914,000 -15,730,000 -15,378,000 -22,976,000
Income Tax Expense 0 0 0 -126,000
Net Income -18,914,000 -15,730,000 -15,378,000 -22,976,000
Per Share
EPS -0.27 -0.22 -0.22 -0.45
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Revenue 0 0 0 0 0
Cost of Revenue 31,000 36,000 382,000 256,000 0
Gross Profit -31,000 -36,000 -382,000 -256,000 0
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 18,367,000 14,644,000 12,177,000 9,357,000 7,392,000
Operating Expenses 79,894,000 70,423,000 55,990,000 41,612,000 22,379,000
Operating Income -79,894,000 -70,423,000 -55,990,000 -41,843,000 -22,894,000
Interest Expense 0 0 0 1,807,000 375,000
Income Before Tax -74,412,000 -68,459,000 -51,787,000 -41,060,000 -20,902,000
Income Tax Expense 0 0 -137,895 -2,279,000 0
Net Income -74,412,000 -68,459,000 -51,787,000 -38,781,000 -20,902,000
Per Share
EPS -0.98 -1.33 -1.01 -2.13 -2.72
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 94,107,000 70,396,000 16,036,000 150,410,000
Short Term Investments 73,751,000 56,478,000 85,860,000 0
Net Receivables 700,000 0 0 0
Inventory 0 0 0 0
Total Current Assets 171,145,000 128,652,999 104,910,000 152,104,000
Property Plant Equipment 1,420,000 1,983,000 2,193,000 168,000
Goodwill and Intangibles 0 0 0 0
Total Assets 175,490,000 132,737,000 123,721,000 152,420,000
Liabilities
Account Payables 5,809,000 4,901,000 3,269,000 1,132,000
Short Term Debt 632,000 568,000 541,000 108,000
Total Current Liabilities 11,912,000 9,606,000 5,200,000 2,462,000
Long Term Debt 983,000 1,660,000 1,937,000 80,000
Total Liabilities 13,363,000 11,734,000 7,549,000 2,949,000
Shareholders Equity
Retained Earnings -403,856,000 -329,444,000 -260,985,000 -209,198,000
Total Shareholders Equity 162,127,000 121,003,000 116,172,000 149,471,000
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Assets
Cash and Cash Equivalents 94,107,000 70,396,000 16,036,000 150,410,000 41,047,000
Short Term Investments 73,751,000 56,478,000 85,860,000 0 0
Net Receivables 700,000 0 0 0 0
Inventory 0 0 0 0 0
Total Current Assets 171,145,000 128,652,999 104,910,000 152,104,000 41,993,000
Property Plant Equipment 1,420,000 1,983,000 2,193,000 168,000 425,000
Goodwill and Intangibles 0 0 0 0 0
Total Assets 175,490,000 132,737,000 123,721,000 152,420,000 42,609,000
Liabilities
Account Payables 5,809,000 4,901,000 3,269,000 1,132,000 1,035,000
Short Term Debt 632,000 568,000 541,000 108,000 265,000
Total Current Liabilities 11,912,000 9,606,000 5,200,000 2,462,000 1,968,000
Long Term Debt 983,000 1,660,000 1,937,000 80,000 14,155,000
Total Liabilities 13,363,000 11,734,000 7,549,000 2,949,000 16,510,000
Shareholders Equity
Retained Earnings -403,856,000 -329,444,000 -260,985,000 -209,198,000 -168,138,000
Total Shareholders Equity 162,127,000 121,003,000 116,172,000 149,471,000 26,099,000
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income -74,412,000 -68,459,000 -51,787,000 -41,060,000
Depreciation & Amortization 31,000 36,000 30,000 13,000
Stock Based Compensation 7,121,000 7,360,000 7,268,000 3,685,000
Change in Working Capital 47,000 3,100,000 1,021,000 -642,000
Operating Cash Flow -69,075,000 -57,368,000 -44,481,000 -39,616,000
Investing Activities
Capital Expenditure 0 0 -153,000 0
Investments 0 0 -153,000 0
Investing Cash Flow -14,541,000 48,699,000 -101,464,000 0
Financing Activities
Debt Repayment 0 0 0 -16,013,000
Common Stock Issued/Repurchased 107,327,000 49,017,000 12,330,000 112,037,000
Dividends Paid 0 0 0 0
Financing Cash Flow 107,327,000 63,029,000 11,571,000 148,979,000
Summary
Free Cash Flow -69,075,000 -57,368,000 -44,634,000 -39,616,000
Net Change in Cash 23,711,000 54,360,000 -134,374,000 109,363,000
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Activities
Net Income -74,412,000 -68,459,000 -51,787,000 -41,060,000 -20,902,000
Depreciation & Amortization 31,000 36,000 30,000 13,000 13,000
Stock Based Compensation 7,121,000 7,360,000 7,268,000 3,685,000 3,965,000
Change in Working Capital 47,000 3,100,000 1,021,000 -642,000 -2,120,000
Operating Cash Flow -69,075,000 -57,368,000 -44,481,000 -39,616,000 -20,441,000
Investing Activities
Capital Expenditure 0 0 -153,000 0 0
Investments 0 0 -153,000 0 0
Investing Cash Flow -14,541,000 48,699,000 -101,464,000 0 0
Financing Activities
Debt Repayment 0 0 0 -16,013,000 0
Common Stock Issued/Repurchased 107,327,000 49,017,000 12,330,000 112,037,000 41,000,000
Dividends Paid 0 0 0 0 0
Financing Cash Flow 107,327,000 63,029,000 11,571,000 148,979,000 51,533,000
Summary
Free Cash Flow -69,075,000 -57,368,000 -44,634,000 -39,616,000 -20,441,000
Net Change in Cash 23,711,000 54,360,000 -134,374,000 109,363,000 31,092,000